Shari Huval
Papers
2
Total Citations
25
H-Index
2
About
Shari Huval is a key figure in the rapid deployment of high-throughput diagnostic testing during the COVID-19 pandemic. Her primary research focus lies in the buildout, integration, and operationalization of automated Clinical Laboratory Improvement Amendments (CLIA) laboratories, specifically designed for large-scale viral testing. Huval’s major contribution is her detailed, practical framework for rapidly establishing a high-volume SARS-CoV-2 testing facility on a large urban campus, a critical need during the early stages of the global health crisis. Her most-cited work, a 2022 paper detailing this process, has garnered 19 citations, while a companion overview from 2021 has received 6. These publications serve as vital blueprints for other institutions, outlining the logistical, technical, and regulatory challenges of scaling up testing capacity in a crisis. By translating complex laboratory requirements into actionable protocols, Huval’s work has directly enabled faster pandemic response and provided a replicable model for future public health emergencies, solidifying her impact on clinical laboratory science and infectious disease management.
Research Focus
Key Achievements
Top Papers
- 1
- 2